Cargando…

Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value

Nonalcoholic fatty liver disease (NAFLD) refers to fatty liver disease caused by liver injury factors other than alcohol. The disease is characterized by diffuse fat infiltration, including simple steatosis (no inflammatory fat deposition), nonalcoholic fatty hepatitis, liver fibrosis, and so on, wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yu-Qi, Xin, Lei, Zhao, Yu-Chi, Li, Shang-Qi, Li, Ya-Nuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308292/ https://www.ncbi.nlm.nih.gov/pubmed/37397934 http://dx.doi.org/10.4254/wjh.v15.i6.786

Ejemplares similares

Mediterranean diet and nonalcoholic fatty liver disease
por: Anania, Caterina, et al.
Publicado: (2018)

Emerging role of engineered exosomes in nonalcoholic fatty liver disease
por: Ding, Jian, et al.
Publicado: (2023)

Vascular endothelial growth factor protein and gene delivery by novel nanomaterials for promoting liver regeneration after partial hepatectomy
por: Jin, Yun, et al.
Publicado: (2023)

Associations between nonalcoholic fatty liver disease and ischemic stroke
por: Alkagiet, Stelina, et al.
Publicado: (2018)

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
por: Pirola, Carlos J, et al.
Publicado: (2018)

Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics
por: Di Sessa, Anna, et al.
Publicado: (2021)

Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis
por: Zhang, Yang, et al.
Publicado: (2021)

Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
por: Mattos, Ângelo Z, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic
por: Ahmed, Musaab, et al.
Publicado: (2021)

Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current status
por: Kiseleva, Yana V, et al.
Publicado: (2023)

Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
por: Chackelevicius, Carla Melisa, et al.
Publicado: (2016)

Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system
por: Pirola, Carlos Jose, et al.
Publicado: (2021)

Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives
por: Ueno, Masayuki, et al.
Publicado: (2022)

Research progress on the mitochondrial mechanism of age-related non-alcoholic fatty liver
por: Wang, Dan, et al.
Publicado: (2023)

Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management
por: Wibawa, I Dewa Nyoman, et al.
Publicado: (2023)

Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease
por: Pacifico, Lucia, et al.
Publicado: (2018)

Liver injury in COVID-19: Detection, pathogenesis, and treatment
por: Cai, Yue, et al.
Publicado: (2021)

Pathological process of liver sinusoidal endothelial cells in liver diseases
por: Ni, Yao, et al.
Publicado: (2017)

Screening of aptamers and their potential application in targeted diagnosis and therapy of liver cancer
por: Zhang, Guo-Qing, et al.
Publicado: (2019)

Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022)

Artificial intelligence in medical imaging of the liver
por: Zhou, Li-Qiang, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Management of non-alcoholic fatty liver disease patients with sleep apnea syndrome
por: Sheng, Wei, et al.
Publicado: (2022)

Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view
por: Chen, Hui-Ting, et al.
Publicado: (2020)

Fatty liver and celiac disease: Why worry?
por: Narciso-Schiavon, Janaina Luz, et al.
Publicado: (2023)

Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients
por: Yousef, Mohamad H, et al.
Publicado: (2017)

Growing challenge of post-liver transplantation non-alcoholic fatty liver disease
por: Kalogirou, Maria Styliani, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease and cardiovascular risk
por: Patil, Rashmee, et al.
Publicado: (2017)

COVID-19 and pediatric fatty liver disease: Is there interplay?
por: Di Sessa, Anna, et al.
Publicado: (2021)

Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis
por: Seen, Tasur Kumar, et al.
Publicado: (2021)

Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
por: Ocker, Matthias
Publicado: (2020)

Metabolic associated fatty liver disease: Addressing a new era in liver transplantation
por: Gill, Madeleine G, et al.
Publicado: (2020)

The ETS Factor, ETV2: a Master Regulator for Vascular Endothelial Cell Development
por: Oh, Se-Yeong, et al.
Publicado: (2015)

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
por: Wong, Carrie R, et al.
Publicado: (2016)

Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Said, Adnan, et al.
Publicado: (2017)

Obese children with fatty liver: Between reality and disease mongering
por: Ranucci, Giusy, et al.
Publicado: (2017)

Management of metabolic-associated fatty liver disease: The diabetology perspective
por: Jeeyavudeen, Mohammad Sadiq, et al.
Publicado: (2023)

Diagnostic value of imaging examinations in patients with primary hepatocellular carcinoma
por: Li, Xing-Hui, et al.
Publicado: (2018)

De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation
por: Han, Ma Ai Thanda, et al.
Publicado: (2021)

Racial differences in prevalence and severity of non-alcoholic fatty liver disease
por: Bonacini, Maurizio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2iobedkutp2m2s06kqk99s12og